The role of bone radiotherapy during immune checkpoint inhibitors treatment of non-small-cell lung cancer: a single-institution experience
Background: Immune checkpoint inhibitors (ICIs) represent a keystone of cancer treatment, including non-small-cell lung cancer (NSCLC). Unfortunately, the efficacy of ICIs remains poor in patients with bone metastases from NSCLC. Recently, several case reports have suggested the clinical benefit of...
Saved in:
| Main Authors: | Ivan Facilissimo, Guido Natoli, Fabio Gaspari, Tiziana Comandone, Diego Bongiovanni, Paola Gollini, Claudia Provenza, Alessandro Comandone |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-05-01
|
| Series: | Therapeutic Advances in Medical Oncology |
| Online Access: | https://doi.org/10.1177/17588359251332451 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advances in radiotherapy enhancing the efficacy of immune checkpoint inhibitors in malignant
by: Yao Liao, et al.
Published: (2025-07-01) -
A Systematic Review of Pneumonitis Following Treatment with Immune Checkpoint Inhibitors and Radiotherapy
by: Melina Yerolatsite, et al.
Published: (2025-04-01) -
Roles of the phagocytosis checkpoint in radiotherapy
by: Yulan Kui, et al.
Published: (2025-08-01) -
Single Institution Experience with Immune Checkpoint Inhibitors in Vulvar and Vaginal Melanomas
by: Amrita Ladwa, et al.
Published: (2024-01-01) -
Characteristics and innovative points of clinical trials of radiotherapy combined with immune checkpoint inhibitors in NSCLC over the past decade
by: Mengting Li, et al.
Published: (2025-07-01)